• Twist Bioscience CEO Emily M. Leproust sold 5,203 shares of common stock on Sep. 24, 2026.
• Sales prices ranged from USD 175.2313 to USD 184.603 per share.
• Directly held stake fell to 613,699 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-011980), on September 25, 2026, and is solely responsible for the information contained therein.